iPSCs from Non-Human Species

iPSCs from Non-Human Species

Birbrair, Alexander

161,20 €(IVA inc.)

The series Advances in Stem Cell Biology is a timely and expansive collection of comprehensive information and new discoveries in the field of stem cell biology. iPSC from Non-Human Species, Volume 10 addresses how important induced pluripotent stems cells are and how can they be used in patient-specific disease models. Somatic cells can be reprogrammed into induced pluripotent stem cells by the expression of specific transcription factors. These cells have been transforming biomedical research over the last 15 years. This volume will address the advances in research of how induced pluripotent stem cells from various, species such as: bovine, equine, non-human primate, rat, etc., are being used for treatment of different diseases. The volume is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine and organ transplantation; and is contributed by world-renowned authors in the field. Provides overview of the fast-moving field of stem cell biology and function, regenerative medicine and therapeuticsCovers equine, non-human primate, porcine, canine, prairie vole, rabbit, naked mole rat, and other speciesContributed by world-renown experts in the field INDICE: 1. Delivery strategies for immune checkpoint blockade inhibitors 2. Delivery strategies for ex vivo and in vivo T-cell reprogramming 3. Delivery strategies for ex vivo and in vivo NK cell reprogramming 4. Delivery strategies for tumor-associated macrophage reprogramming 5. Reprogramming lymphocytes for tumor immunotherapy 6. Targeting tumor-associated neutrophils in immunotherapy 7. Targeting tumor-associated fibroblast in immunotherapy 8. Oncolytic viral particle delivery 9. Extracellular vesicles (exosomes) in tumor immunotherapy 10. Nucleic acid-based delivery and reprogramming for tumor immuno-oncology 11. CRISPR-based gene editing in cancer immunotherapy 12. Delivery strategies for glioma immunotherapy 13. Delivery strategies for STING agonists 14. Delivery strategies for cancer vaccine and immunoadjuvant 15. Targeted delivery and reprogramming myeloid-derived suppressor cells (MDSC) in cancer 16. Delivery of radio-immunotherapy for solid tumors 17. Delivery of photo-immunotherapy for cancer 18. Local immunotherapy of cancer and metastasis 19. Delivery strategies to overcome tumor immunotherapy resistance

  • ISBN: 978-0-12-823809-7
  • Editorial: Academic Press
  • Encuadernacion: Rústica
  • Páginas: 300
  • Fecha Publicación: 01/06/2021
  • Nº Volúmenes: 1
  • Idioma: Inglés